• 中国科技期刊卓越行动计划项目资助期刊
  • 中国精品科技期刊
  • 首都科技期刊卓越行动计划
  • EI
  • Scopus
  • CAB Abstracts
  • Global Health
  • 北大核心期刊
  • DOAJ
  • EBSCO
  • 中国核心学术期刊RCCSE A+
  • 中国科技核心期刊CSTPCD
  • JST China
  • FSTA
  • 中国农林核心期刊
  • 中国开放获取期刊数据库COAJ
  • CA
  • WJCI
  • 食品科学与工程领域高质量科技期刊分级目录第一方阵T1
中国精品科技期刊2020
杜金,郝薛宇,于洪梅,等. 基于副干酪乳杆菌细胞外囊泡的虾青素递送系统构建及其抗疲劳作用研究J. 食品工业科技,2026,47(14):1−10. doi: 10.13386/j.issn1002-0306.2025060291.
引用本文: 杜金,郝薛宇,于洪梅,等. 基于副干酪乳杆菌细胞外囊泡的虾青素递送系统构建及其抗疲劳作用研究J. 食品工业科技,2026,47(14):1−10. doi: 10.13386/j.issn1002-0306.2025060291.
DU Jin, HAO Xueyu, YU Hongmei, et al. Construction of an Astaxanthin Delivery System Based on Lactobacillus paracasei Extracellular Vesicles and Its Anti-Fatigue EffectJ. Science and Technology of Food Industry, 2026, 47(14): 1−10. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2025060291.
Citation: DU Jin, HAO Xueyu, YU Hongmei, et al. Construction of an Astaxanthin Delivery System Based on Lactobacillus paracasei Extracellular Vesicles and Its Anti-Fatigue EffectJ. Science and Technology of Food Industry, 2026, 47(14): 1−10. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2025060291.

基于副干酪乳杆菌细胞外囊泡的虾青素递送系统构建及其抗疲劳作用研究

Construction of an Astaxanthin Delivery System Based on Lactobacillus paracasei Extracellular Vesicles and Its Anti-Fatigue Effect

  • 摘要: 目的:利用副干酪乳杆菌来源的细胞外囊泡(EVs)作为递送载体,构建虾青素(AST)封装体系(AST@EVs),以改善其水溶性、稳定性及生物利用度。方法:采用差速离心与超速离心分离EVs,并通过表征分析、体外模拟消化、自由基清除实验及C2C12细胞模型,系统评价AST@EVs的理化特性、消化稳定性、抗氧化活性与抗疲劳作用。结果:成功制备出典型球形结构且平均粒径为85.97 nm的EVs,在优化封装比例(2:1)后,AST@EVs的封装率和蛋白载量分别达到84.94%和12.74%,粒径增大至109.37 nm,且红外与电镜结果证实AST被有效封装。体外消化中AST@EVs的AST保留率显著(P<0.05)高于游离AST及物理混合组;其DPPH和ABTS+自由基清除率分别达83.92%和62.81%,抗氧化能力显著(P<0.01)提升。细胞实验表明,AST@EVs可促进C2C12细胞对AST的摄取(5.27±0.21 μg/mL),缓解氧化应激,调节超氧化物歧化酶、过氧化氢酶活性并降低丙二醛水平,同时抑制乳酸脱氢酶和肌酸激酶升高,增强糖原储存并恢复线粒体功能相关酶活性。结论:基于EVs的封装策略可显著增强AST的稳定性、抗氧化能力及抗疲劳功效,为功能性食品与抗疲劳药物开发提供了新思路。

     

    Abstract: The present study aimed to utilize extracellular vesicles (EVs) derived from Lactobacillus paracasei as delivery carriers to construct an astaxanthin (AST)-encapsulated system (AST@EVs), thereby improving the water solubility, stability, and bioavailability of AST. The research methods included the isolation of EVs via differential centrifugation and ultracentrifugation. Systematic evaluations of the physicochemical properties, digestive stability, antioxidant activity, and anti-fatigue effect of AST@EVs were conducted using characterization analysis, in vitro simulated digestion, free radical scavenging assays, and the C2C12 cell model. The results demonstrated that EVs with a typical spherical structure and an average particle size of 85.97 nm were successfully prepared. After optimizing the encapsulation ratio (2:1), the encapsulation efficiency and protein loading capacity of AST@EVs reached 84.94% and 12.74%, respectively, with the particle size increasing to 109.37 nm. Additionally, Fourier transform infrared spectroscopy (FTIR) and electron microscopy results confirmed the effective encapsulation of AST in EVs. In in vitro digestion, the retention rate of AST in AST@EVs was significantly higher than that in the free AST group and the physical mixture group. The scavenging rates of AST@EVs against 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) cation radical (ABTS+) were 83.92% and 62.81%, respectively, indicating a significant enhancement in antioxidant capacity. Cellular experiments showed that AST@EVs could promote the uptake of AST by C2C12 cells (reaching 5.27 μg/mL), alleviate oxidative stress, regulate the activities of superoxide dismutase (SOD) and catalase (CAT), and reduce the level of malondialdehyde (MDA). Meanwhile, AST@EVs inhibited the increase in lactate dehydrogenase (LDH) and creatine kinase (CK) activities, enhanced glycogen storage, and restored the activities of enzymes related to mitochondrial function. In conclusion, the EV-based encapsulation strategy can significantly enhance the stability, antioxidant capacity, and anti-fatigue efficacy of AST. This study provides a new idea for the development of functional foods and anti-fatigue drugs.

     

/

返回文章
返回